An Extended Cost-Effectiveness Analysis of Publicly Financed HPV Vaccination to Prevent Cervical Cancer in China

Review
In: Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Nov 1. Chapter 18.

Excerpt

Cervical cancer is one of the 10 most common diseases affecting women in China. Although the average national estimates of the cervical cancer burden in China are low, the burden may be underestimated because the prevalence of the human papillomavirus (HPV) is high. Cervical cancer mortality is heterogeneous across geographic settings (Li, Kang, and Qiao 2011); it is highest among poor women living in Gansu, Shanxi, and Shaanxi, the least developed provinces in central and western China.

Publication types

  • Review